{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:59:53Z","timestamp":1767135593976,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd007795","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T00:00:00Z","timestamp":1300233600000}}],"reference-count":45,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007795.pub2","type":"journal-article","created":{"date-parts":[[2011,3,9]],"date-time":"2011-03-09T18:06:26Z","timestamp":1299693986000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Vaccination for preventing postherpetic neuralgia"],"prefix":"10.1002","author":[{"given":"Ning","family":"Chen","sequence":"first","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qifu","family":"Li","sequence":"additional","affiliation":[{"name":"The Affiliated Hospital of Hainan Medical College; Department of Neurology; 31 Longhua Road Haikou Hainan Province China 570102"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muke","family":"Zhou","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Zhou","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"He","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Neurology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,3,16]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD007795.pub2-BIB0002|cit1","first-page":"12","article-title":"Herpes zoster vaccine safe and effective for older adults","volume":"47","author":"Oxman","year":"2005","journal-title":"South African Family Practice"},{"issue":"22","key":"10.1002\/14651858.CD007795.pub2-BIB0001|cit2","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD007795.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-152-9-201005040-00004","article-title":"Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial","volume":"152","author":"Simberkoff","year":"2010","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD007795.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa013441","article-title":"Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants","volume":"347","author":"Hata","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007795.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CVI.00310-07","article-title":"A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax","volume":"15","author":"Gilderman","year":"2008","journal-title":"Clinical and Vaccine Immunology"},{"issue":"2","key":"10.1002\/14651858.CD007795.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/infdis\/166.2.253","article-title":"Immune response of elderly individuals to a live attenuated varicella vaccine","volume":"166","author":"Levin","year":"1992","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007795.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1086\/514264","article-title":"Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect","volume":"178","author":"Levin","year":"1998","journal-title":"Journal of Infectious Diseases"},{"issue":"25","key":"10.1002\/14651858.CD007795.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/S0264-410X(99)00552-6","article-title":"Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older","volume":"18","author":"Levine","year":"2000","journal-title":"Vaccine"},{"issue":"11","key":"10.1002\/14651858.CD007795.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.vaccine.2006.11.011","article-title":"Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults","volume":"25","author":"Macaladad","year":"2007","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD007795.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1016\/j.vaccine.2010.04.003","article-title":"Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster","volume":"28","author":"Mills","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD007795.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/infdis\/165.5.852","article-title":"Kinetics and viral protein specificity of the cytotoxic T lymphocyte response in healthy adults immunized with live attenuated varicella vaccine","volume":"165","author":"Sharp","year":"1992","journal-title":"Journal of Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD007795.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.vaccine.2006.10.027","article-title":"Safety and tolerability of a high-potency zoster vaccine in adults \u226550 years of age","volume":"25","author":"Tyring","year":"2007","journal-title":"Vaccine"},{"issue":"16","key":"10.1002\/14651858.CD007795.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0264-410X(99)00510-1","article-title":"Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial","volume":"18","author":"Trannoy","year":"2000","journal-title":"Vaccine"},{"issue":"11","key":"10.1002\/14651858.CD007795.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD007795.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0166-3542(85)80037-1","article-title":"Booster vaccination of healthy adults with VZV antibody but without a VZV-specific cell-mediated immune response","volume":"Suppl 1","author":"Berger","year":"1985","journal-title":"Antiviral Research"},{"key":"10.1002\/14651858.CD007795.pub2-BIB0016|cit16","unstructured":"Centers for Disease Control and Prevention Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR. Morbidity and Mortality Weekly Report. Recommendations and Reports 2008 1 30"},{"issue":"2","key":"10.1002\/14651858.CD007795.pub2-BIB0017|cit17","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005582.pub3","article-title":"Corticosteroids for preventing postherpetic neuralgia","author":"Chen","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007795.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/infdis\/172.3.706","article-title":"The epidemiology of varicella and its complications","volume":"172","author":"Choo","year":"1995","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD007795.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1468-1331.2004.00791.x","article-title":"EFNS guidelines on neuropathic pain assessment","volume":"11","author":"Cruccu","year":"2004","journal-title":"European Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD007795.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0885-3924(02)00393-7","article-title":"Clinical applications for change-point analysis of herpes zoster pain","volume":"23","author":"Desmond","year":"2002","journal-title":"Journal of Pain and Symptom Management"},{"issue":"6","key":"10.1002\/14651858.CD007795.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/01.WNL.0000140708.62856.72","article-title":"Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"63","author":"Dubinsky","year":"2004","journal-title":"Neurology"},{"issue":"8913","key":"10.1002\/14651858.CD007795.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/S0140-6736(94)93106-2","article-title":"Proposed classification of herpes zoster pain","volume":"343","author":"Dworkin","year":"1994","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD007795.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1086\/368196","article-title":"Treatment and prevention of postherpetic neuralgia","volume":"36","author":"Dworkin","year":"2003","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD007795.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Clinical practice: herpes zoster","volume":"347","author":"Gnann","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD007795.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.pmed.0020164","article-title":"Analgesic therapy in postherpetic neuralgia: a quantitative systematic review","volume":"2","author":"Hempenstall","year":"2005","journal-title":"PLoS Medicine"},{"issue":"11","key":"10.1002\/14651858.CD007795.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD007795.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007795.pub2-BIB0028|cit28","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2008"},{"issue":"1","key":"10.1002\/14651858.CD007795.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/003591576505800106","article-title":"The nature of herpes zoster: a long term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proceedings of the Royal Society of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD007795.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-145-5-200609050-00004","article-title":"Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"145","author":"Hornberger","year":"2006","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD007795.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/421942","article-title":"Acute pain in herpes zoster and its impact on health-related quality of life","volume":"39","author":"Katz","year":"2004","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD007795.pub2-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004846.pub2","article-title":"Topical lidocaine for the treatment of postherpetic neuralgia","author":"Khaliq","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD007795.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1086\/514264","article-title":"Use of live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect","volume":"178","author":"Levin","year":"1998","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD007795.pub2-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006866.pub2","article-title":"Antiviral treatment for preventing postherpetic neuralgia","author":"Li","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD007795.pub2-BIB0035|cit35","first-page":"1075","article-title":"Herpes zoster and postherpetic neuralgia: prevention and management","volume":"72","author":"Mounsey","year":"2005","journal-title":"American Family Physician"},{"key":"10.1002\/14651858.CD007795.pub2-BIB0036|cit36","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"key":"10.1002\/14651858.CD007795.pub2-BIB0037|cit37","unstructured":"Rohan P FDA Clinical Briefing Document for Merck & Co., Inc. Zoster vaccine live (Oka\/Merck) Zostavax Vaccines and Related Biological Products Advisory Committee"},{"issue":"4","key":"10.1002\/14651858.CD007795.pub2-BIB0038|cit38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005454.pub2","article-title":"Antidepressants for neuropathic pain","author":"Saarto","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD007795.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","article-title":"Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy","volume":"18","author":"Schmader","year":"2002","journal-title":"Clinical Journal of Pain"},{"issue":"8","key":"10.1002\/14651858.CD007795.pub2-BIB0040|cit40","first-page":"2447","article-title":"Management of herpes zoster (shingles) and postherpetic neuralgia","volume":"61","author":"Stankus","year":"2000","journal-title":"American Family Physician"},{"issue":"1","key":"10.1002\/14651858.CD007795.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1473-3099(03)00857-0","article-title":"What does epidemiology tell us about risk factors for herpes zoster?","volume":"4","author":"Thomas","year":"2004","journal-title":"Lancet Infectious Diseases"},{"issue":"16","key":"10.1002\/14651858.CD007795.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0264-410X(99)00510-1","article-title":"Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial","volume":"18","author":"Trannoy","year":"2000","journal-title":"Vaccine"},{"key":"10.1002\/14651858.CD007795.pub2-BIB0043|cit43","unstructured":"Document\u00a0for\u00a0the\u00a0Vaccines\u00a0and\u00a0Related\u00a0Biological\u00a0Products\u00a0Advisory\u00a0Committee (VRBPAC) FDA\u00a0Statistical\u00a0Review\u00a0and\u00a0Evaluation"},{"issue":"2","key":"10.1002\/14651858.CD007795.pub2-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007793","article-title":"Acupuncture for postherpetic neuralgia","author":"Wang","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"23","key":"10.1002\/14651858.CD007795.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM198312083092306","article-title":"Varicella and herpes zoster. Changing concepts of the nature history, control, and importance of a not-so-benign virus","volume":"309","author":"Weller","year":"1983","journal-title":"New England Journal of Medicine"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007795.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:13:52Z","timestamp":1628532832000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007795.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,3,16]]},"references-count":45,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007795.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,16]]}}}